Description:

AMC-053 Enrollment Form (ENR) Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma NCT00598169 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8B73192C-C22B-46D4-E040-BB89AD433800

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8B73192C-C22B-46D4-E040-BB89AD433800

Keywords:

4/19/12 4/19/12 -
2/4/15 2/4/15 - Martin Dugas
2/4/15 2/4/15 - Martin Dugas

Uploaded on:

February 4, 2015

DOI:

To request one please log in.

License :

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Registration Enrollment Form (ENR AMC-053 )

No Instruction available.

StudyEvent: AMC-053 Enrollment Form (ENR)
1. No Instruction available.

Header Module

Principal Investigator

Projected Start Date of Treatment

mm/dd/yyyy

Karnofsky Performance Status

Date Informed Consent Signed

mm/dd/yyyy

Comments

Inclusion Criteria

Inclusion Criteria

years

Exclusion Criteria

Active hepatitis B infection

Yes

No

Back to the top of the page

Similar models

Show recommended models

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.